Tohyama J - Search Results

1

Differences in levetiracetam and perampanel treatment-related irritability in patients with epilepsy.

Hasegawa N, Tohyama J. Hasegawa N, et al. Among authors: tohyama j. Epilepsy Behav. 2021 Mar;116:107644. doi: 10.1016/j.yebeh.2020.107644. Epub 2021 Feb 3. Epilepsy Behav. 2021. PMID: 33549477 Free article.

2

Early-onset absence epilepsy at eight months of age.

Kobayashi Y, Akasaka N, Ohashi T, Saitoh S, Tomonoh Y, Hirose S, Tohyama J. Kobayashi Y, et al. Among authors: tohyama j. Epileptic Disord. 2011 Dec;13(4):417-21. doi: 10.1684/epd.2011.0477. Epileptic Disord. 2011. PMID: 22258047 Free article.

3

Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.

Kobayashi Y, Tohyama J, Takahashi Y, Goto T, Haginoya K, Inoue T, Kubota M, Fujita H, Honda R, Ito M, Kishimoto K, Nakamura K, Sakai Y, Takanashi JI, Tanaka M, Tanda K, Tominaga K, Yoshioka S, Kato M, Nakashima M, Saitsu H, Matsumoto N. Kobayashi Y, et al. Among authors: tohyama j. Brain Dev. 2021 Apr;43(4):505-514. doi: 10.1016/j.braindev.2020.12.006. Epub 2021 Jan 9. Brain Dev. 2021. PMID: 33436160 Free article.

4

Positive and negative effects of perampanel treatment on psychiatric and behavioral symptoms in adult patients with epilepsy.

Hasegawa N, Tohyama J. Hasegawa N, et al. Among authors: tohyama j. Epilepsy Behav. 2021 Apr;117:107515. doi: 10.1016/j.yebeh.2020.107515. Epub 2021 Feb 17. Epilepsy Behav. 2021. PMID: 33610462

5

Recurrence rates and risk factors for seizure recurrence following antiseizure medication withdrawal in adolescent patients with genetic generalized epilepsy.

Komatsubara T, Kobayashi Y, Hiraiwa A, Magara S, Hojo M, Ono T, Okazaki K, Fukuda M, Tohyama J. Komatsubara T, et al. Among authors: tohyama j. Epilepsia Open. 2022 Jun;7(2):332-343. doi: 10.1002/epi4.12603. Epub 2022 Apr 28. Epilepsia Open. 2022. PMID: 35445562 Free PMC article.

6

Acquired opercular epilepsy with oromotor dysfunction: magnetoencephalographic analysis and efficacy of corticosteroid therapy.

Tohyama J, Akasaka N, Ohashi T, Kobayashi Y. Tohyama J, et al. J Child Neurol. 2011 Jul;26(7):885-90. doi: 10.1177/0883073810393307. Epub 2011 Feb 15. J Child Neurol. 2011. PMID: 21325126

7

Infantile epileptic encephalopathy with a hyperkinetic movement disorder and hand stereotypies associated with a novel SCN1A mutation.

Ohashi T, Akasaka N, Kobayashi Y, Magara S, Kawashima H, Matsumoto N, Saitsu H, Tohyama J. Ohashi T, et al. Among authors: tohyama j. Epileptic Disord. 2014 Jun;16(2):208-12. doi: 10.1684/epd.2014.0649. Epileptic Disord. 2014. PMID: 24776920 Free article.

8

Three cases of right frontal megalencephaly: Clinical characteristics and long-term outcome.

Ono Y, Saito Y, Maegaki Y, Tohyama J, Montassir H, Fujii S, Sugai K, Ohno K. Ono Y, et al. Among authors: tohyama j. Brain Dev. 2016 Mar;38(3):302-9. doi: 10.1016/j.braindev.2015.09.005. Epub 2015 Sep 26. Brain Dev. 2016. PMID: 26415548

9

A Single-Arm Open-Label Clinical Trial on the Efficacy and Safety of Sirolimus for Epileptic Seizures Associated with Focal Cortical Dysplasia Type II: A Study Protocol.

Kada A, Tohyama J, Shiraishi H, Takahashi Y, Nakagawa E, Akiyama T, Saito AM, Inoue Y, Kato M. Kada A, et al. Among authors: tohyama j. Kurume Med J. 2021 Jul 21;66(2):115-120. doi: 10.2739/kurumemedj.MS662007. Epub 2021 Jun 15. Kurume Med J. 2021. PMID: 34135202 Free article.

10

Clinical and electroencephalographic findings prior to the onset of juvenile myoclonic epilepsy: A case series.

Hiraiwa A, Kobayashi Y, Hojo M, Tohyama J. Hiraiwa A, et al. Among authors: tohyama j. Epileptic Disord. 2023 Feb;25(1):80-86. doi: 10.1002/epd2.20052. Epub 2023 Apr 17. Epileptic Disord. 2023. PMID: 36946369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page